IPH4102

Drug identity checked against registry records

Also recorded as lacutamab

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
IPH4102/Lacutamab Alone or in Combination With Chemotherapy in Patients With Advanced T Cell LymphomaNCT03902184Innate PharmaPhase 2Completed2026-01-08Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.